PRICES include / exclude VAT
Homepage>BS Standards>11 HEALTH CARE TECHNOLOGY>11.040 Medical equipment>11.040.40 Implants for surgery, prosthetics and orthotics>BS EN ISO 5840-3:2021 Cardiovascular implants. Cardiac valve prostheses Heart valve substitutes implanted by transcatheter techniques
Sponsored link
immediate downloadReleased: 2021-02-08
BS EN ISO 5840-3:2021 Cardiovascular implants. Cardiac valve prostheses Heart valve substitutes implanted by transcatheter techniques

BS EN ISO 5840-3:2021

Cardiovascular implants. Cardiac valve prostheses Heart valve substitutes implanted by transcatheter techniques

Format
Availability
Price and currency
English Secure PDF
Immediate download
377.00 USD
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
37.70 USD
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
113.10 USD
English Hardcopy
In stock
377.00 USD
Standard number:BS EN ISO 5840-3:2021
Pages:66
Released:2021-02-08
ISBN:978 0 539 02794 5
Status:Standard
DESCRIPTION

BS EN ISO 5840-3:2021


This standard BS EN ISO 5840-3:2021 Cardiovascular implants. Cardiac valve prostheses is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics

This document is applicable to all devices intended for implantation as a transcatheter heart valve substitute.

This document is applicable to transcatheter heart valve substitutes and to the accessory devices, packaging and labelling required for their implantation and for determining the appropriate size of heart valve substitute to be implanted.

This document establishes an approach for verifying/validating the design and manufacture of a transcatheter heart valve substitute through risk management. The selection of appropriate verification/validation tests and methods are to be derived from the risk assessment. The tests can include those to assess the physical, chemical, biological and mechanical properties of heart valve substitutes and of their materials and components. The tests can also include those for preclinical in vivo evaluation and clinical evaluation of the finished heart valve substitute.

This document defines operational conditions and performance requirements for transcatheter heart valve substitutes where adequate scientific and/or clinical evidence exists for their justification.

This document includes considerations for implantation of a transcatheter heart valve substitute inside a pre-existing prosthetic device (e.g. valve-in-valve and valve-in-ring configurations).